Posts Tagged ‘clinical trial’
Sickle cell anemia treatment safely lowers disease burden in African children
A daily hydroxyurea pill may finally bring some relief for young children living with the painful and deadly blood disease sickle cell anemia (SCA) in resource-challenged sub-Saharan Africa …
Read Full ArticleGlobal trial shows CAR T-cell therapy can lead to durable remissions in non-Hodgkin’s lymphoma
In an update to a global clinical trial stretching from Philadelphia to four continents, the chimeric antigen receptor (CAR) T cell therapy Kymriah® …
Read Full Article91 percent response rate for venetoclax against newly diagnosed AML in older adults
Clinical trial results show 91 percent response rate to the combination of venetoclax with azacitidine in older adults newly diagnosed with AML. …
Read Full ArticleResearchers find promise in new treatment for peanut allergy
Controlled ingestion of peanut protein could help build tolerance in peanut allergy sufferers. Authors of a new study published in the New England Journal of Medicine say an oral immunotherapy drug they tested …
Read Full ArticleDrug reduces chances of second heart attack or stroke
In a clinical trial involving 18,924 patients from 57 countries who had suffered a recent heart attack or threatened heart attack, researchers at the University of Colorado Anschutz Medical Campus and fellow scientists around the world …
Read Full ArticleResearchers find wheat oral immunotherapy to be therapeutic for allergic patients
In a major step towards understanding the safety and efficacy of wheat oral immunotherapy, Mount Sinai researchers report promising results from the first …
Read Full ArticleImmunotherapy effective as first-line treatment for advanced head and neck cancer
Immunotherapy on its own is better than aggressive chemotherapy as a first-line treatment for advanced head and neck cancer, according to surprising new data from a major phase III clinical trial. …
Read Full ArticleImmune therapy generates promising results in hard-to-treat ankylosing spondylitis
Results from a phase 3 clinical trial indicate that patients who have not benefited from standard therapy for ankylosing spondylitis (AS), a chronic inflammatory disease characterized by back pain and sacroiliac-joint …
Read Full ArticleDNA vaccine leads to immune responses in HPV-related head and neck cancer
A therapeutic vaccine can boost antibodies and T cells, helping them infiltrate tumors and fight off human papillomavirus (HPV)-related head and neck cancer. Researchers from the Abramson Cancer Center …
Read Full ArticleDaily low-dose aspirin found to have no effect on healthy life span in older people
In a large clinical trial to determine the risks and benefits of daily low-dose aspirin in healthy older adults without previous cardiovascular events, aspirin did not prolong healthy, independent living …
Read Full Article